Search results for "Bowel disease"

showing 10 items of 449 documents

Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies …

1996

There is now increasing evidence that hyperresponsiveness towards intestinal flora is a crucial event in the pathogenesis of inflammatory bowel disease (IBD). In support of this hypothesis, we recently described in humans that tolerance exists towards indigenous intestinal flora but is broken in active IBD lesions. In the present study, we have attempted to transfer this model into mice from different genetic backgrounds (BALB/c, SJL/J, C3H/HeJ). We found that mononuclear cells from spleen, small bowel and large bowel of mice do not proliferate, i.e. are tolerant when exposed to bacterial sonicates derived from autologous intestine (BsA) but do proliferate, i.e. are immune when exposed to b…

ColonImmunologySpleenBiologyLymphocyte ActivationInflammatory bowel diseaseMicrobiologyMicePeyer's PatchesImmune systemCrohn DiseaseSpecies SpecificityImmunityIntestine SmallImmune TolerancemedicineAnimalsHumansImmunologic FactorsImmunology and AllergyColitisMice Inbred BALB CMice Inbred C3HBacteriaAntibodies MonoclonalInterleukinColitismedicine.diseaseInterleukin-12Recombinant ProteinsInterleukin-10RatsSpecific Pathogen-Free OrganismsIntestinesDisease Models AnimalInterleukin 10medicine.anatomical_structureTrinitrobenzenesulfonic AcidImmunologyLeukocytes MononuclearInterleukin 12SpleenEuropean Journal of Immunology
researchProduct

Efficient gene delivery to the inflamed colon by local administration of recombinant adenoviruses with normal or modified fibre structure

1999

BACKGROUND/AIMSReplication deficient recombinant adenoviruses represent an efficient means of transferring genes in vivo into a wide variety of dividing and quiescent cells from many different organs. Although the gastrointestinal tract is a potentially attractive target for gene therapy approaches, only a few studies on the use of viral gene transfer vehicles in the gut have been reported. The prospects of using recombinant adenoviruses for gene delivery into epithelial and subepithelial cells of the normal and inflamed colon are here analysed.METHODSAn E1/E3 deleted recombinant adenovirus (denoted AdCMVβGal) and an adenovirus with modified fibre structure (denoted AdZ.F(pk7)) both express…

ColonT cellGenetic enhancementGenetic VectorsGene ExpressionBiologyGene deliverymedicine.disease_causeRecombinant virusArticleAdenoviridaeMiceAdministration RectalGene expressionmedicineAnimalsHumansReporter geneLamina propriaMice Inbred BALB CGastroenterologyGene Transfer TechniquesDefective VirusesColitisInflammatory Bowel Diseasesbeta-GalactosidaseVirologyMolecular biologyAdenoviridaemedicine.anatomical_structureInjections IntravenousInjections Intraperitoneal
researchProduct

EXTRACELLULAR VESCICLES DERIVED FROM GUT MICROBIOTA IN INFLAMMATORY BOWEL DISEASE AND COLORECTAL CANCER

2021

The human gut microbiome encompasses inter alia, the myriad bacterial species that create the optimal host-micro-organism balance essential for normal metabolic and immune function. Various lines of evidence suggest that dys-regulation of the microbiota-host interaction is linked to pathologies such as inflammatory bowel disease (IBD) and colorectal cancer (CRC). Extracellular vesicles (EVs), found in virtually all body fluids and produced by both eukaryotic cells and bacteria are involved in cell-cell communication and crosstalk mechanisms, such as the immune response, barrier function and intestinal flora. This review highlights advancements in knowledge of the functional role that EVs ma…

Colorectal cancerGut microbiotaGut floraInflammatory bowel diseaseInflammatory bowel diseaseGeneral Biochemistry Genetics and Molecular BiologyExtracellular VesiclesImmune systemFlora (microbiology)HumansMedicineMicrobiomeBarrier functionBacteriabiologybusiness.industryMicrobiotaRInflammatory Bowel Diseasesmedicine.diseasebiology.organism_classificationColorectal cancerdigestive system diseasesGastrointestinal MicrobiomeCrosstalk (biology)ImmunologyMedicinecolo-rectal cancer extracellular vescicles gut microbiota inflammatory bowel dseaseColorectal Neoplasmsbusiness
researchProduct

Cytokines in Colitis-Associated Cancer: Potential Drug Targets?

2008

In inflammatory bowel disease (IBD), such as UC and CD, the development of colorectal carcinoma can be initiated through chronic inflammation, depending on the duration and severity of the disease. Growing evidence supports a role for various cytokines, released by epithelial and immune cells, in the pathogenesis of colitis associated cancer (CAC). For instance, TNF-alpha has been recently shown to promote tumor development in experimental colitis. Due to its role in the pathogenesis of IBD, TNF-alpha blockade has become one of the cornerstones of IBD therapy. Thus, anti-TNF-alpha strategies could also provide effective anti-tumor therapies. TGF-beta has been shown to attenuate an anti-tumo…

Colorectal cancerImmunologyInflammationInflammatory bowel diseasePathogenesisImmune systemT-Lymphocyte SubsetsAnimalsHumansImmunology and AllergyMedicineColitisPharmacologyInterleukin-6Tumor Necrosis Factor-alphabusiness.industryCancerGeneral MedicineColitisInflammatory Bowel Diseasesmedicine.diseaseInterleukin-12Interleukin-10ImmunologyCytokinesTumor necrosis factor alphamedicine.symptomColorectal NeoplasmsbusinessInflammation & Allergy - Drug Targets
researchProduct

Mucosal immunology and probiotics.

2013

The cross-talk between the mucosa-associated immune system and microbiota is critical in mucosal tissue homeostasis as well as in protection against infectious and inflammatory diseases occurring at mucosal sites. This recent evidence has paved the way to therapeutic approaches aimed at modulating the mucosa-associated immune system using probiotics. Different strains of probiotics possess the ability to finely regulate dendritic cell (DC) activation, polarizing the subsequent T cell activity toward Th1 (e.g. Lactobacillus (Lb) acidophilus), Th2 (Lb.reuteri and Bifidobacterium bifidum) or, as more recently demonstrated, Th17 responses induced by specific strains such as Lb.rhamnosus GG and …

Commensal bacteriaSettore MED/07 - Microbiologia E Microbiologia ClinicaAllergyPRRT- cell polarizationved/biology.organism_classification_rank.speciesAutoimmunityProbioticInflammatory bowel diseaseMALTTh1Th2Immunology and AllergyIECBifidobacteriumbiologyMicrobiotaImmune-mediated diseasefood and beveragesPAMPCrohn's diseasemedicine.anatomical_structureMucosal immunologyImmunotherapyTh17HumanPulmonary and Respiratory MedicineSettore MED/17 - Malattie InfettiveT cellImmunologyImmunopathologyDendritic CellMicrobiologyImmune systemBifidobacteriaImmunityTLRmedicineGALTAnimalsHumansImmunity MucosalLABLactobacilluInnate immune systemBifidobacterium bifidumUlcerative colitiMucous Membraneved/biologyAnimalProbioticsDendritic cellDendritic CellsInterleukinbiology.organism_classificationImmunity InnateLactobacillusMucosal immunologyLactobacilliImmune SystemImmunologyBifidobacteriumCurrent allergy and asthma reports
researchProduct

Corneal thickness and intraocular pressure in pediatric patients with Celiac disease or Inflammatory Bowel Disease

Corneal thicknessSettore MED/38 - Pediatria Generale E SpecialisticaInflammatory Bowel DiseaseCeliac diseaseintraocular pressure
researchProduct

P178 Remote monitoring as an effective management strategy in inflammatory bowel disease: the lesson from COVID-19 pandemic

2021

Abstract Background During the COVID-19 outbreaks many IBD clinics in Italy adopted a remote monitoring approach both to ensure an adequate follow-up of patients with inflammatory bowel disease (IBD) and respect the rules of social distancing, while access to hospital was restricted. Aim of the study was to perform a survey on IBD patients submitted to remote monitoring in our tertiary referral center in order to assess adherence and patients’ perceptions and satisfaction as well as their opinions for future monitoring. Changes in disease activity and Quality of Life were also evaluated. Methods Consecutive patients with IBD scheduled for follow-up visits were switched to remote monitoring …

Crohn's disease2019-20 coronavirus outbreakmedicine.medical_specialtyTelemedicineCoronavirus disease 2019 (COVID-19)business.industryGastroenterologyEffective managementGeneral Medicinemedicine.diseaseClinical: Diagnosis and OutcomeInflammatory bowel diseasePoster presentationsQuality of life (healthcare)PandemicMedicinebusinessIntensive care medicineAcademicSubjects/MED00260Journal of Crohn's and Colitis
researchProduct

Pathogenesis of Crohn’s disease: Bug or no bug

2015

The possibility of an infectious origin in inflammatory bowel disease (IBD) has been postulated since the first description of Crohn’s disease (CD). Many observations implicate bacteria as a trigger for the development of CD: lesions occur in regions with higher bacterial concentrations; aphthous ulcers occur in Peyer’s patches; inflammation resolves when the fecal stream is diverted and is reactivated following reinfusion of bowel contents; severity of the disease is correlated with bacterial density in the mucosa; granulomas can contain bacteria; and susceptible mice raised in germ-free conditions develop inflammation when bacteria are introduced in the 1990’s, several studies sought to e…

Crohn's diseaseCampylobacterInflammationDiseaseReviewBiologymedicine.diseasemedicine.disease_causeInflammatory bowel diseaseUlcerative colitisVirusMicrobiologyPathogenesisImmunologymedicinemedicine.symptom
researchProduct

Chronic Urticaria as a presenting symptom of Crohn’s disease.

2009

Clinical presentation of Crohn’s disease (CD) may be variable according to the location and the intensity of the inflammation. Some patients may have atypical symptoms which could delay the diagnosis. We report the first case of chronic urticaria related to a subclinical, complicated CD. Although the pathologic mechanism of this association was unclear in our patient, this case suggests that in patients with unexplained chronic urticaria it is opportune to investigate for a possible CD, even if there are no or few specific symptoms of intestinal inflammatory disease.

Crohn's diseasePathologymedicine.medical_specialtySettore MED/09 - Medicina Internabusiness.industryInflammationGeneral MedicineDiseasemedicine.diseaseInflammatory bowel diseaseDermatologyArticlechronic urticariaCrohn's diseaseMedicineIn patientmedicine.symptomchronic urticaria; Crohn's diseasebusinessChronic urticariaSubclinical infection
researchProduct

DOP21 Role of P2X7 in intestinal fibrosis and inflammasome activation: Relevance in Crohn′s Disease

2021

Abstract Background Crohn’s disease (CD) is a chronic inflammatory disorder of the gastrointestinal tract whose etiology is unknown. CD is associated with complications such as fibrosis or fistula, which cannot be pharmacologically reversed, requiring repeated surgery. Although a profibrotic effect of the P2X7 receptor has been described in some scenarios such as lung, heart and liver, its role in intestinal fibrosis has not been analysed yet. Given the crosstalk between fibrosis and inflammasome, we aim to analyze the relevance of P2X7 in intestinal fibrosis and inflammasome activation. Methods Surgical intestinal resections of CD patients and healthy ileum of carcinoma patients were obtai…

Crohn's diseasebusiness.industryGastroenterologyCaspase 1InflammasomeGeneral Medicinemedicine.diseaseInflammatory bowel diseaseFibrosisImmunologymedicineInterleukin 18ColitisbusinessIrritable bowel syndromemedicine.drugJournal of Crohn's and Colitis
researchProduct